ESR1 and breast cancer: It has been reported that BZ blocks the catabolic process of autophagy via a cathepsin-dependent mechanism in estrogen receptor-positive breast cancer cells (16), whereas other reports demonstrated that BZ induces autophagy in myeloma cells, prostatic cancer cells, endothelial cells, and breast cancer cells (9,15,40,43,44).